Annals of Oncology

Articles Available on Medscape

• Targeted Next-Generation Sequencing of Circulating-Tumor DNA for Tracking Minimal Residual Disease in Localized Colon Cancer
  Find out about the potential role of plasma circulating-tumor DNA in determining minimal residual disease in patients with localized colon cancer.

  February 10, 2020

• Breast Cancer Index and Prediction of Benefit From Extended Endocrine Therapy in Breast Cancer Patients Treated in the Adjuvant Tamoxifen -- To Offer More? (aTTom) Trial
  Might the Breast Cancer Index effectively predict benefit from extended endocrine treatment? Data from the aTTom trial provides insight.

  January 27, 2020

• The Negative Impact of Antibiotics on Outcomes in Cancer Patients Treated With Immunotherapy
  What impact do antibiotic-related changes of the gut microbiome have on efficacy of immune-checkpoint inhibitors?

  January 20, 2020

• Estimating the Benefits of Therapy for Early-Stage Breast Cancer
  Based on the new evidence, which loco-regional and systemic therapies have the most impact on risk of recurrence and overall survival in early breast cancer?

  January 06, 2020

• A Phase II Feasibility Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor-Positive Invasive Breast Carcinoma
  In a new study, patients with HR+/HER2- early stage breast cancer completed 2 years of adjuvant palbociclib with a similar toxicity profile as that observed in the metastatic setting.

  November 13, 2019

Table of Contents

2023 - 34 (3)

• Excellent response to olaparib in metastatic HR-positive, HER2-negative breast cancer with BRIP1 mutation. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• "Timing is Everything": the evolving role of immune checkpoint inhibition in nasopharyngeal carcinoma. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785]. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29]. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Corrigendum to "Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation": [Annals of Oncology 28 (2017):2503-2510]. 

  March 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]